Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1CNS 1Breast 1

Conditions

Brain Neoplasms 3Urogenital Neoplasms 2Neoplasms, Unknown Primary 2Glioma 2Breast Neoplasms 2Thyroid Neoplasms 1Spinal Cord Neoplasms 1Sarcoma 1Prostatic Neoplasms 1Pheochromocytoma 1Paraganglioma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neurofibromatosis 1 1Neoplastic Syndromes, Hereditary 1Melanoma 1Kidney Neoplasms 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Dyslexia 1Digestive System Neoplasms 1Colorectal Neoplasms 1Central Nervous System Neoplasms 1Bone Neoplasms 1

Interventions

fludarabine 1alectinib 1Stem Cell Transplantation 1Sirolimus 1Melphalan 1Genetic Testing 1Genetic Counseling 1Busulfan 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Digestive System Neoplasms × Genetic Testing × CNS × Clear all
NCT04456140 2023-07-24

Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study

Mayo Clinic

Phase 1 Completed
230 enrolled
BreastCNSGastrointestinalHead & Neck

Brain Neoplasms, Breast Neoplasms, Digestive System Neoplasms, Head and Neck Neoplasms, Neoplasms, Unknown Primary, Urogenital Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡